Header Logo

Connection

Lydia Usha to Cystadenocarcinoma, Serous

Back to Details
This is a "connection" page, showing publications Lydia Usha has written about Cystadenocarcinoma, Serous.
Lydia Usha
Connection Strength
0.814
Cystadenocarcinoma, Serous
  1. A Durable Response to Pembrolizumab in a Patient with Uterine Serous Carcinoma and Lynch Syndrome due to the MSH6 Germline Mutation. Oncologist. 2021 10; 26(10):811-817.
    View in: PubMed
    Score: 0.814
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.